Apr 12, 2021 / 07:45PM GMT
Michael Stephen Matson - Needham & Company, LLC, Research Division - Senior Analyst
Good afternoon, everyone. Thanks for joining us at the 20th Annual Needham Healthcare Conference. I'm Mike Matson, senior research analyst on the medtech and diagnostics team here. With me is Masimo's Vice President of Corporate Development and Investor Relations, Eli Kammerman.
This will be a fireside chat, so we're going to go straight into the questions. Feel free to submit questions of your own through the box on the top right of your screen. I'll do my best to fit them in to the conversation.
Questions and Answers:
Michael Stephen Matson - Needham & Company, LLC, Research Division - Senior AnalystSo I want to start out with some kind of general questions and some on kind of the pandemic and current environment. So just given where things currently stand with the vaccine rollout, in COVID-19 infection rates, what's your latest thinking about the procedure volume recovery this year? Are things better or worse than you expected kind of coming into the
Trustpilot
